We are live on
!
Find out more
RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$9.44B
1-Year Est. Return
68.42%
This Fund
S&P 500
This Quarter
Est. Return
+6.82%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$1.27B
AUM Growth
+$199M
(+19%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
12.92%
Top 10 Holdings %
Top 10 Hldgs %
54.41%
Holding
79
New
19
Increased
11
Reduced
13
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corteva
CTVA
|
+$45.7M |
| 2 |
Cameco
CCJ
|
+$45.1M |
| 3 |
Bunge Global
BG
|
+$37.3M |
| 4 |
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$34M |
| 5 |
Valero Energy
VLO
|
+$26.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$48.2M |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$38.4M |
| 3 |
BERY
Berry Global Group, Inc.
BERY
|
+$37.8M |
| 4 |
Heron Therapeutics
HRTX
|
+$36.7M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$36.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.71% |
| 2 | Technology | 12.43% |
| 3 | Industrials | 11.49% |
| 4 | Energy | 9.77% |
| 5 | Materials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
iShares Russell 2000 ETF
IWM
$81.6B
| $317M | 24.98% |
+2,040,000
| New | +$314M |
|
|
AMRN
2
Amarin Corp
AMRN
$296M
| $52.4M | 4.12% |
135,000
+22,500
| +20% | +$8.24M |
|
|
3
Corteva
CTVA
$51B
| $50.3M | 3.96% |
+1,700,000
| New | +$45.7M |
|
|
4
Cameco
CCJ
$39.1B
| $45M | 3.54% |
+4,189,496
| New | +$45.1M |
|
|
STML
5
DELISTED
Stemline Therapeutics, Inc.
STML
| $43.3M | 3.41% |
2,826,404
-178,596
| -6% | -$2.58M |
|
6
WillScot Mobile Mini Holdings
WSC
$4.66B
| $40.2M | 3.17% |
2,676,000
| – | – |
|
|
RDUS
7
DELISTED
Radius Health, Inc.
RDUS
| $39.9M | 3.14% |
1,639,034
-353,044
| -18% | -$7.72M |
|
|
8
Bunge Global
BG
$20.2B
| $39M | 3.07% |
+700,000
| New | +$37.3M |
|
9
BGC Group
BGC
$5.38B
| $33.6M | 2.65% |
6,422,617
+1,986,718
| +45% | +$10.3M |
|
|
SAIL
10
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $30.1M | 2.37% |
+1,500,000
| New | +$34M |
|
|
COOP
11
DELISTED
Mr. Cooper
COOP
| $29M | 2.29% |
3,626,116
| – | – |
|
|
12
Valero Energy
VLO
$88.5B
| $27.3M | 2.15% |
+318,590
| New | +$26.3M |
|
13
Conduent
CNDT
$270M
| $27.1M | 2.13% |
2,825,000
+1,241,000
| +78% | +$13.4M |
|
14
JetBlue
JBLU
$2.35B
| $26.7M | 2.1% |
1,443,486
+700,000
| +94% | +$12.5M |
|
15
Magnachip Semiconductor
MX
$126M
| $25.4M | 2% |
2,449,507
-405,996
| -14% | -$3.71M |
|
16
Saic
SAIC
$5.08B
| $25.1M | 1.98% |
290,200
-351,853
| -55% | -$27.6M |
|
17
Target Hospitality
TH
$1.58B
| $22.8M | 1.79% |
2,500,000
| – | – |
|
|
SAVE
18
DELISTED
Spirit Airlines, Inc.
SAVE
| $20.5M | 1.62% |
430,000
+145,000
| +51% | +$7.39M |
|
|
PRSP
19
DELISTED
Perspecta Inc. Common Stock
PRSP
| $20.3M | 1.59% |
865,000
-35,000
| -4% | -$786K |
|
20
Green Plains
GPRE
$1.16B
| $19.9M | 1.56% |
1,842,743
-378,786
| -17% | -$5.63M |
|
21
Scorpio Tankers
STNG
$3.91B
| $19.7M | 1.55% |
668,330
+168,330
| +34% | +$4.26M |
|
22
Constellium
CSTM
$3.85B
| $19.3M | 1.52% |
1,917,813
| – | – |
|
23
MBIA
MBI
$267M
| $18.9M | 1.49% |
2,028,001
-383,399
| -16% | -$3.58M |
|
24
Owens Corning
OC
$11.5B
| $18.3M | 1.44% |
+313,600
| New | +$16M |
|
25
Hilton Grand Vacations
HGV
$3.53B
| $18.2M | 1.43% |
572,104
| – | – |
|
Similar funds
SCM
RCM
SIM
NPT
AC
PVI
WPL
BAMF
Rubric Capital Management (New York)'s Q2 2019 Portfolio in Review
As of Q2 2019, Rubric Capital Management (New York) held 79 positions worth $1.27B, up 19% from $1.07B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Rubric Capital Management (New York) deployed $164M of net new capital in Q2 2019, opening 19 new positions and adding to 11 existing holdings. Its largest new stake was Corteva: 1,700,000 shares worth $50.3M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Coherus Oncology, an estimated $33.7M trimmed.
- Rubric Capital Management (New York)'s largest Q2 2019 buy was Corteva: 1,700,000 shares worth $50.3M.
- Rubric Capital Management (New York) added most to Conduent in Q2 2019, an estimated $13.4M increase.
- Rubric Capital Management (New York)'s biggest Q2 2019 reduction was Coherus Oncology, cutting an estimated $33.7M.
- Rubric Capital Management (New York) fully exited Viatris in Q2 2019, selling an estimated $48.2M.
- Rubric Capital Management (New York)'s ten largest holdings make up 54% of its $1.27B portfolio in Q2 2019.
- Rubric Capital Management (New York) opened 19 new positions and closed 25 in Q2 2019.
- Rubric Capital Management (New York)'s portfolio value rose 19% quarter-over-quarter to $1.27B.
Based on Rubric Capital Management (New York)'s 13F filing for Q2 2019, filed 13 Aug 2019.